Suppr超能文献

头颈部晚期癌症患者接受放化疗治疗前后的嗓音和言语结局:专家听众和患者的感知。

Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.

机构信息

Department of Head and Neck Oncology & Surgery, The Netherlands Cancer Institute, Plesmanlaan, Amsterdam, The Netherlands.

出版信息

J Voice. 2012 Sep;26(5):664.e25-33. doi: 10.1016/j.jvoice.2011.08.016. Epub 2011 Dec 29.

Abstract

OBJECTIVES

Perceptual judgments and patients' perception of voice and speech after concurrent chemoradiotherapy (CCRT) for advanced head and neck cancer.

STUDY DESIGN

Prospective clinical trial.

METHODS

A standard Dutch text and a diadochokinetic task were recorded. Expert listeners rated voice and speech quality (based on Grade, Roughness, Breathiness, Asthenia, and Strain), articulation (overall, [p], [t], [k]), and comparative mean opinion scores of voice and speech at three assessment points calculated. A structured study-specific questionnaire evaluated patients' perception pretreatment (N=55), at 10-week (N=49) and 1-year posttreatment (N=37).

RESULTS

At 10 weeks, perceptual voice quality is significantly affected. The parameters overall voice quality (mean, -0.24; P=0.008), strain (mean, -0.12; P=0.012), nasality (mean, -0.08; P=0.009), roughness (mean, -0.22; P=0.001), and pitch (mean, -0.03; P=0.041) improved over time but not beyond baseline levels, except for asthenia at 1-year posttreatment (voice is less asthenic than at baseline; mean, +0.20; P=0.03). Perceptual analyses of articulation showed no significant differences. Patients judge their voice quality as good (score, 18/20) at all assessment points, but at 1-year posttreatment, most of them (70%) judge their "voice not as it used to be." In the 1-year versus 10-week posttreatment comparison, the larynx-hypopharynx tumor group was more strained, whereas nonlarynx tumor voices were judged less strained (mean, -0.33 and +0.07, respectively; P=0.031). Patients' perceived changes in voice and speech quality at 10-week post- versus pretreatment correlate weakly with expert judgments.

CONCLUSION

Overall, perceptual CCRT effects on voice and speech seem to peak at 10-week posttreatment but level off at 1-year posttreatment. However, at that assessment point, most patients still perceive their voice as different from baseline.

摘要

目的

评估头颈部癌症患者接受同期放化疗(CCRT)后嗓音和言语的感知判断和患者感知。

研究设计

前瞻性临床试验。

方法

记录标准荷兰语文本和双音节词测试。由专家听众根据等级、粗糙度、呼吸音、乏力和紧张度对嗓音和言语质量进行评分,并在三个评估点计算言语和嗓音的综合平均意见评分。一份结构特定的研究调查问卷在治疗前(N=55)、10 周时(N=49)和 1 年时(N=37)评估患者的感知。

结果

10 周时,嗓音感知质量受到明显影响。总体嗓音质量(平均,-0.24;P=0.008)、紧张度(平均,-0.12;P=0.012)、鼻音度(平均,-0.08;P=0.009)、粗糙度(平均,-0.22;P=0.001)和音调(平均,-0.03;P=0.041)参数随时间改善,但未超过基线水平,除 1 年后的乏力外(嗓音比基线时更乏力;平均,+0.20;P=0.03)。发音感知分析未显示出显著差异。患者在所有评估点都认为自己的嗓音质量良好(评分,18/20),但在 1 年后,大多数人(70%)认为自己的“嗓音不再像以前那样”。在 1 年与 10 周的比较中,喉下咽肿瘤组的嗓音更紧张,而非喉肿瘤的嗓音则被认为不那么紧张(平均,-0.33 和+0.07,分别;P=0.031)。患者在 10 周时嗓音和言语质量感知的变化与专家判断的相关性较弱。

结论

总体而言,CCRT 对嗓音和言语的感知影响似乎在治疗后 10 周达到高峰,然后在 1 年后趋于稳定。然而,在该评估点,大多数患者仍认为自己的嗓音与基线时不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验